Home

HARMONY PLUS

 

HARMONY Alliance Partners and Asssociated Members meet at the General Assembly 2023
HARMONY Alliance highlights of 2022
End of year message and HARMONY Alliance highlights of 2022
New results at the Annual Meeting of the American Society of Hematology
CML-5: Prevalence of clinically relevant problems and symptoms in patients with CML
CML-3: A comparison study of toxicity over time and QoL among all available TKI options
CML-4: Correlation of demographic, disease and therapy factors with toxicity and tolerability of the different TKIs
CML-2: Using Big Data to Map and Identify Optimal Treatment Pathways to Treatment-Free Remission in CML
Engaging participation of consulting and informing Patient organizations and patients
MPN: Delphi Survey Project: Towards a Core Outcome Set for Myeloproliferative Neoplasms (MPN)
HL: Delphi Survey Project: Towards a Core Outcome Set for Hodgkin’s Lymphoma (HL)
CML: Delphi Survey Project: Towards a Core Outcome Set for Chronic Myeloid Leukemia (CML)
WM: Delphi Survey Project: Towards a Core Outcome Set for Waldenström Macroglobulinaemia (WM)
Inspiring HARMONY Alliance General Assembly 2021 - 6th edition HARMONY - 2nd edition HARMONY PLUS
CML-1: Understanding the clonal hierarchy in Chronic Myeloid Leukemia to help improve patient outcomes
Connect with us at the EHA2021 Virtual Congress and learn about new HARMONY results
#Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach.
#Bigdataforbloodcancer Blog: The HARMONY Alliance - a balance between Big Data and Cybersecurity, with a real impact on patients with Hematological tumors
MPN-2: Using big data to improve risk prediction in patients with MPN
MPN-1: Exploring the Impact of Covid-19 on Outcomes in Myeloproliferative Neoplasms